Roni P. Dodiuk-Gad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Roni P. Dodiuk-Gad has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
Michael Ziv
Dermatology Department, Emek Medical Center, Afula, Israel
8 shared publications- Neil H. Shear
Division of Dermatology Department of Medicine Sunnybrook Health Sciences Centre Toronto ON Canada
5 shared publications Neil H. Shear
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada
4 shared publicationsCristina Olteanu
Division of Dermatology, Department of Medicine, University of Alberta, Edmonton, Canada
3 shared publications- Felix L. Chan
Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
3 shared publications - Hemali Shah
Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, USA
3 shared publications
Latest Publications
- Open Access
- 3 March 2026
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 27 (2) , 247-260
Mastering the Use of Systemic JAK Inhibitors for Atopic Dermatitis: A Dermatologist's Practical Guide
Atopic dermatitis (AD) is one of the most frequent conditions treated by dermatologists. The therapeutic options for moderate-to-severe AD are rapidly expanding with the introduction of biologics and Janus kinase inhibitors (JAKis). There are currently three oral JAKis approved for the treatment of AD, namely abrocitinib, baricitinib and upadacitinib. Although JAKis are rapidly effective for treating AD and its symptoms, they require careful patient selection and monitoring due to a side-effect profile which includes an increased risk of major adverse cardiovascular events (MACE) and malignancies, especially in patients with pre-existing risk factors. The aim of this article is to provide practical recommendations on how to prescribe, monitor and manage potential adverse reactions of systemic JAKis for AD, and to assist dermatologists in navigating various scenarios that can be encountered in clinic.
- 3 March 2026
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 27 (2) , 247-260
Open AccessMastering the Use of Systemic JAK Inhibitors for Atopic Dermatitis: A Dermatologist's Practical Guide
Atopic dermatitis (AD) is one of the most frequent conditions treated by dermatologists. The therapeutic options for moderate-to-severe AD are rapidly expanding with the introduction of biologics and Janus kinase inhibitors (JAKis). There are currently three oral JAKis approved for the treatment of AD, namely abrocitinib, baricitinib and upadacitinib. Although JAKis are rapidly effective for treating AD and its symptoms, they require careful patient selection and monitoring due to a side-effect profile which includes an increased risk of major adverse cardiovascular events (MACE) and malignancies, especially in patients with pre-existing risk factors. The aim of this article is to provide practical recommendations on how to prescribe, monitor and manage potential adverse reactions of systemic JAKis for AD, and to assist dermatologists in navigating various scenarios that can be encountered in clinic.
- Open Access
- 25 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 384
The Role of AI-Generated Clinical Image Descriptions in Enhancing Teledermatology Diagnosis: A Cross-Sectional Exploratory Study
Background/Objectives: AI models such as ChatGPT-4 have shown strong performance in dermatology; however, the diagnostic value of AI-generated clinical image descriptions remains underexplored. This study assesses whether ChatGPT-4’s image descriptions can support accurate dermatologic diagnosis and evaluates their potential integration into the Electronic Medical Record (EMR) system. Materials & Methods: In this Exploratory cross-sectional study, we analyzed images and descriptions from teledermatology consultations conducted between December 2023 and February 2024. ChatGPT-4 generated clinical descriptions for each image, which two senior dermatologists then used to formulate differential diagnoses. Diagnoses based on ChatGPT-4’s output were compared to those derived from the original clinical notes written by teledermatologists. Concordance was categorized as Top1 (exact match), Top3 (correct within top three), Partial, or No match. Results: The study included 154 image descriptions from 67 male and 87 female patients, aged 0 to 93 years. ChatGPT-4 descriptions averaged 74.3 ± 33.1 words, compared to 7.9 ± 3.0 words for teledermatologists. At least one of the two dermatologists achieved a Top 3 concordance rate of 82.5% using ChatGPT-4’s descriptions and 85.3% with teledermatologist descriptions. Conclusions: Preliminary findings highlight the potential integration of ChatGPT-4-generated descriptions into EMRs to enhance documentation. Although AI descriptions were longer, they did not enhance diagnostic accuracy, and expert validation remained essential.
- 25 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 384
Open AccessThe Role of AI-Generated Clinical Image Descriptions in Enhancing Teledermatology Diagnosis: A Cross-Sectional Exploratory Study
Background/Objectives: AI models such as ChatGPT-4 have shown strong performance in dermatology; however, the diagnostic value of AI-generated clinical image descriptions remains underexplored. This study assesses whether ChatGPT-4’s image descriptions can support accurate dermatologic diagnosis and evaluates their potential integration into the Electronic Medical Record (EMR) system. Materials & Methods: In this Exploratory cross-sectional study, we analyzed images and descriptions from teledermatology consultations conducted between December 2023 and February 2024. ChatGPT-4 generated clinical descriptions for each image, which two senior dermatologists then used to formulate differential diagnoses. Diagnoses based on ChatGPT-4’s output were compared to those derived from the original clinical notes written by teledermatologists. Concordance was categorized as Top1 (exact match), Top3 (correct within top three), Partial, or No match. Results: The study included 154 image descriptions from 67 male and 87 female patients, aged 0 to 93 years. ChatGPT-4 descriptions averaged 74.3 ± 33.1 words, compared to 7.9 ± 3.0 words for teledermatologists. At least one of the two dermatologists achieved a Top 3 concordance rate of 82.5% using ChatGPT-4’s descriptions and 85.3% with teledermatologist descriptions. Conclusions: Preliminary findings highlight the potential integration of ChatGPT-4-generated descriptions into EMRs to enhance documentation. Although AI descriptions were longer, they did not enhance diagnostic accuracy, and expert validation remained essential.
- 20 November 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (3) , 600-601
Darier disease is a syndromic epidermal differentiation disorder
This letter is a comment on the previous publication, ‘Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy’ by Paller et al.
- 20 November 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (3) , 600-601
Darier disease is a syndromic epidermal differentiation disorder
This letter is a comment on the previous publication, ‘Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy’ by Paller et al.
- Open Access
- 26 September 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (1) , 161-163
Long-term morbidity and quality of life in survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum
This is one of the largest long-term studies following an SJS/TEN reaction that reports long-term survey-based sequelae and adds to the understanding of SJS/TEN as a condition with chronic complications long beyond the acute reaction. We report significant long-term life impacts among survivors of SJS/TEN in the USA. Additional follow-up and long-term care of this patient population is of the utmost importance.
- 26 September 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (1) , 161-163
Open AccessLong-term morbidity and quality of life in survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum
This is one of the largest long-term studies following an SJS/TEN reaction that reports long-term survey-based sequelae and adds to the understanding of SJS/TEN as a condition with chronic complications long beyond the acute reaction. We report significant long-term life impacts among survivors of SJS/TEN in the USA. Additional follow-up and long-term care of this patient population is of the utmost importance.
- Open Access
- 25 April 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (5) , 883-884
Darier disease: Golden era of discovery and global collaborations
- 25 April 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (5) , 883-884
Open AccessDarier disease: Golden era of discovery and global collaborations
- Open Access
Failed Metabolic Adaptation to Stress Underlies Pathogenesis in a Heterozygous Genetic Disorder
Disorders linked to heterozygous variants occupy a continuum in terms of the timing and severity of phenotypic emergence. An important question regarding this variability entails the effect stress has on the residual protein function. Using Darier disease (DD), caused by heterozygous variants of the SERCA2 calcium pump, as a model, we uncovered a potential connection between extrinsic stress and pathogenesis. The skin lesions characteristic of DD entail loss of intercellular adhesion and rarely appear pre-adolescence, suggesting that factors beyond heterozygosity contribute to disease pathogenesis. Testing whether age-related stressors contribute to DD, we show that DD patient-derived keratinocytes subjected to stress yield twice the reactive oxygen species of controls, accompanied by greater disruption of intercellular adhesion. Metabolic analysis of DD cells revealed perturbation of the pentose phosphate pathway (PPP), a stress response system responsible for regenerating antioxidants like glutathione. At baseline, DD cells had less free glutathione but an increase in protective glutathione-based modifications of SERCA2, a reversible form of protein oxidation. With stress, DD cells form an aberrant, heavily glutathionylated perinuclear halo consisting of keratin and the intercellular adhesion component, desmoplakin. We propose a model whereby SERCA2 heterozygosity causes mild oxidative stress that under homeostatic conditions can be buffered by glutathionylation. When stressed, the depleted glutathione store is shunted towards the desmoplakin-intermediate filament system at the expense of SERCA2, rendering it vulnerable to damage. A lesional flare, then, would represent a case of more complete SERCA2 inhibition and a novel example of how heterozygous disorders interact with stress to disrupt intercellular adhesion.
Open AccessFailed Metabolic Adaptation to Stress Underlies Pathogenesis in a Heterozygous Genetic Disorder
Disorders linked to heterozygous variants occupy a continuum in terms of the timing and severity of phenotypic emergence. An important question regarding this variability entails the effect stress has on the residual protein function. Using Darier disease (DD), caused by heterozygous variants of the SERCA2 calcium pump, as a model, we uncovered a potential connection between extrinsic stress and pathogenesis. The skin lesions characteristic of DD entail loss of intercellular adhesion and rarely appear pre-adolescence, suggesting that factors beyond heterozygosity contribute to disease pathogenesis. Testing whether age-related stressors contribute to DD, we show that DD patient-derived keratinocytes subjected to stress yield twice the reactive oxygen species of controls, accompanied by greater disruption of intercellular adhesion. Metabolic analysis of DD cells revealed perturbation of the pentose phosphate pathway (PPP), a stress response system responsible for regenerating antioxidants like glutathione. At baseline, DD cells had less free glutathione but an increase in protective glutathione-based modifications of SERCA2, a reversible form of protein oxidation. With stress, DD cells form an aberrant, heavily glutathionylated perinuclear halo consisting of keratin and the intercellular adhesion component, desmoplakin. We propose a model whereby SERCA2 heterozygosity causes mild oxidative stress that under homeostatic conditions can be buffered by glutathionylation. When stressed, the depleted glutathione store is shunted towards the desmoplakin-intermediate filament system at the expense of SERCA2, rendering it vulnerable to damage. A lesional flare, then, would represent a case of more complete SERCA2 inhibition and a novel example of how heterozygous disorders interact with stress to disrupt intercellular adhesion.
- Open Access
- 8 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (6) , 1818
Pruritus and Neuropsychiatric Symptoms Among Patients with Darier Disease—An Overlooked and Interconnected Challenge
(1) Background: Darier disease (DD) is a rare autosomal dominant disorder caused by mutations in ATP2A2, a gene that encodes the sarco(endo)plasmic reticulum calcium-ATPase 2 enzyme, which disrupts calcium homeostasis in keratinocytes. Pruritus, a frequently overlooked symptom in DD, can lead to physical and emotional complications, especially in patients with DD who are genetically predisposed to psychiatric comorbidities. (2) Methods: This study aimed to analyze pruritus and other related symptoms in patients with DD and explore their correlation with neuropsychiatric conditions, psychological challenges, disease severity, and body surface area (BSA) involvement through a retrospective review of a tertiary center. (3) Results: Data from 76 patients (equal gender distribution, mean age 44 years) revealed a prevalence of pruritus of 90.8%, surpassing symptoms such as pain (34.3%) and malodor (43.4%). Burning sensations due to DD lesions were significantly correlated with the diagnosis of comorbid neuropsychiatric conditions (p = 0.047) and psychiatric medication use (p = 0.019). While pruritus correlated with disease severity and %BSA involvement, the findings were not statistically significant. Patients reporting pruritus had a significantly higher Dermatology Life Quality Index symptom score (2.4 ± 1.0), which is defined as the presence of itch, soreness, pain, or stinging, than those who did not (1.5 ± 0.6), indicating accurate symptom reporting. (4) Conclusions: In conclusion, a striking majority of patients with DD experience pruritus, with higher prevalence among those with neuropsychiatric challenges, severe Darier disease, and greater %BSA skin involvement. Clinicians should recognize pruritus as a key therapeutic target and adopt comprehensive treatment approaches that both address the neuropsychiatric comorbidities and the added psychological burden of pruritus in patients with DD.
- 8 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (6) , 1818
Open AccessPruritus and Neuropsychiatric Symptoms Among Patients with Darier Disease—An Overlooked and Interconnected Challenge
(1) Background: Darier disease (DD) is a rare autosomal dominant disorder caused by mutations in ATP2A2, a gene that encodes the sarco(endo)plasmic reticulum calcium-ATPase 2 enzyme, which disrupts calcium homeostasis in keratinocytes. Pruritus, a frequently overlooked symptom in DD, can lead to physical and emotional complications, especially in patients with DD who are genetically predisposed to psychiatric comorbidities. (2) Methods: This study aimed to analyze pruritus and other related symptoms in patients with DD and explore their correlation with neuropsychiatric conditions, psychological challenges, disease severity, and body surface area (BSA) involvement through a retrospective review of a tertiary center. (3) Results: Data from 76 patients (equal gender distribution, mean age 44 years) revealed a prevalence of pruritus of 90.8%, surpassing symptoms such as pain (34.3%) and malodor (43.4%). Burning sensations due to DD lesions were significantly correlated with the diagnosis of comorbid neuropsychiatric conditions (p = 0.047) and psychiatric medication use (p = 0.019). While pruritus correlated with disease severity and %BSA involvement, the findings were not statistically significant. Patients reporting pruritus had a significantly higher Dermatology Life Quality Index symptom score (2.4 ± 1.0), which is defined as the presence of itch, soreness, pain, or stinging, than those who did not (1.5 ± 0.6), indicating accurate symptom reporting. (4) Conclusions: In conclusion, a striking majority of patients with DD experience pruritus, with higher prevalence among those with neuropsychiatric challenges, severe Darier disease, and greater %BSA skin involvement. Clinicians should recognize pruritus as a key therapeutic target and adopt comprehensive treatment approaches that both address the neuropsychiatric comorbidities and the added psychological burden of pruritus in patients with DD.
- Open Access
- 14 November 2024
- Published by Wolters Kluwer Health in International Journal of Women's Dermatology
- Vol. 10 (4) , e184
What do you need to know when preparing to give a talk at an international dermatology conference? Insights and practical recommendations
Objectives: To provide a checklist for presentation preparation at dermatology conferences, discuss important factors to consider when preparing a presentation, and recommend strategies for effective presentations and networking. Data Sources: With a combination of personal experience and literature review of PubMed database and dermatology society resources, this article serves as the first comprehensive guide for how to prepare a talk for an international dermatology conference. Conclusion: Conferences are an excellent opportunity to learn more about yourself, your field, and others throughout the world. Well-prepared presentations have the potential to greatly impact your audience and expand your connections. The authors provide a step-by-step discussion and checklist that thoroughly addresses the logistics, operations, scientific content, and social aspects that are important to know when preparing to give a presentation in the field of dermatology.
- 14 November 2024
- Published by Wolters Kluwer Health in International Journal of Women's Dermatology
- Vol. 10 (4) , e184
Open AccessWhat do you need to know when preparing to give a talk at an international dermatology conference? Insights and practical recommendations
Objectives: To provide a checklist for presentation preparation at dermatology conferences, discuss important factors to consider when preparing a presentation, and recommend strategies for effective presentations and networking. Data Sources: With a combination of personal experience and literature review of PubMed database and dermatology society resources, this article serves as the first comprehensive guide for how to prepare a talk for an international dermatology conference. Conclusion: Conferences are an excellent opportunity to learn more about yourself, your field, and others throughout the world. Well-prepared presentations have the potential to greatly impact your audience and expand your connections. The authors provide a step-by-step discussion and checklist that thoroughly addresses the logistics, operations, scientific content, and social aspects that are important to know when preparing to give a presentation in the field of dermatology.
- Top Cited PapersOpen Access
- 15 September 2024
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 25 (6) , 891-908
Update on Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are the most severe cutaneous adverse reactions that are typically drug-induced in adults. Both SJS and TEN have high morbidity and mortality rates. SJS/TEN imposes clinical challenges for physicians managing patients suffering from this condition, both because it is rare and because it is a rapidly progressing systemic disease with severe cutaneous, mucosal, and systemic manifestations. Although many cases of SJS/TEN have been reported in the literature, there is no consensus regarding diagnostic criteria or treatment. Significant progress has been made in understanding its genetic predisposition and pathogenesis. This review is intended to provide physicians with a comprehensive but practical SJS/TEN roadmap to guide diagnosis and management. We review data on pathogenesis, reported precipitating factors, presentation, diagnosis, and management SJS/TEN focusing on what is new over the last 5 years.
- 15 September 2024
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 25 (6) , 891-908
Top Cited PapersOpen AccessUpdate on Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are the most severe cutaneous adverse reactions that are typically drug-induced in adults. Both SJS and TEN have high morbidity and mortality rates. SJS/TEN imposes clinical challenges for physicians managing patients suffering from this condition, both because it is rare and because it is a rapidly progressing systemic disease with severe cutaneous, mucosal, and systemic manifestations. Although many cases of SJS/TEN have been reported in the literature, there is no consensus regarding diagnostic criteria or treatment. Significant progress has been made in understanding its genetic predisposition and pathogenesis. This review is intended to provide physicians with a comprehensive but practical SJS/TEN roadmap to guide diagnosis and management. We review data on pathogenesis, reported precipitating factors, presentation, diagnosis, and management SJS/TEN focusing on what is new over the last 5 years.
- Open Access
- 18 January 2024
- Published by Wolters Kluwer Health in International Journal of Women's Dermatology
- Vol. 10 (1) , e125
Meeting report: Women’s Dermatology Society Forum at the 25th World Congress of Dermatology, Singapore, 2023
- 18 January 2024
- Published by Wolters Kluwer Health in International Journal of Women's Dermatology
- Vol. 10 (1) , e125
Open AccessMeeting report: Women’s Dermatology Society Forum at the 25th World Congress of Dermatology, Singapore, 2023